EnBio Holdings, Inc (TYO:6092)
730.00
+39.00 (5.64%)
Mar 10, 2026, 3:30 PM JST
EnBio Holdings Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3,913 | 3,293 | 3,604 | 2,828 | 2,371 | 2,015 | Upgrade
|
| Cash & Short-Term Investments | 3,913 | 3,293 | 3,604 | 2,828 | 2,371 | 2,015 | Upgrade
|
| Cash Growth | 15.79% | -8.63% | 27.44% | 19.28% | 17.67% | -32.41% | Upgrade
|
| Receivables | 1,903 | 2,354 | 1,270 | 792 | 1,593 | 948 | Upgrade
|
| Inventory | 3,951 | 2,952 | 2,889 | 3,373 | 1,849 | 3,119 | Upgrade
|
| Other Current Assets | 627 | 358 | 483 | 325 | 645 | 533 | Upgrade
|
| Total Current Assets | 10,394 | 8,957 | 8,246 | 7,318 | 6,458 | 6,615 | Upgrade
|
| Property, Plant & Equipment | 9,026 | 8,827 | 7,918 | 7,016 | 7,914 | 7,332 | Upgrade
|
| Long-Term Investments | 1,900 | 1,403 | 1,375 | 1,186 | 1,221 | 1,012 | Upgrade
|
| Goodwill | 88 | 94 | 102 | 110 | 118 | 126 | Upgrade
|
| Other Intangible Assets | 337 | 351 | 373 | 399 | 427 | 454 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 2 | Upgrade
|
| Other Long-Term Assets | 4 | 2 | 1 | 1 | 2 | 2 | Upgrade
|
| Total Assets | 21,749 | 21,195 | 19,310 | 17,349 | 16,370 | 15,698 | Upgrade
|
| Accounts Payable | 1,005 | 855 | 1,098 | 485 | 693 | 595 | Upgrade
|
| Accrued Expenses | 31 | 41 | 36 | 31 | 50 | - | Upgrade
|
| Short-Term Debt | 972 | 1,788 | 1,088 | 854 | 645 | 955 | Upgrade
|
| Current Portion of Long-Term Debt | 1,943 | 1,666 | 1,300 | 2,293 | 1,276 | 1,050 | Upgrade
|
| Current Income Taxes Payable | 340 | 199 | 183 | 316 | 315 | 20 | Upgrade
|
| Other Current Liabilities | 209 | 269 | 439 | 492 | 467 | 408 | Upgrade
|
| Total Current Liabilities | 4,680 | 4,818 | 4,144 | 4,471 | 3,446 | 3,028 | Upgrade
|
| Long-Term Debt | 7,582 | 6,643 | 6,230 | 5,749 | 6,660 | 7,030 | Upgrade
|
| Other Long-Term Liabilities | 572 | 504 | 347 | 273 | 290 | 323 | Upgrade
|
| Total Liabilities | 12,834 | 11,965 | 10,721 | 10,493 | 10,396 | 10,381 | Upgrade
|
| Common Stock | 2,325 | 2,325 | 2,325 | 1,797 | 1,797 | 1,794 | Upgrade
|
| Additional Paid-In Capital | 2,412 | 2,404 | 2,405 | 1,876 | 1,876 | 1,873 | Upgrade
|
| Retained Earnings | 4,010 | 4,149 | 3,761 | 3,111 | 2,352 | 1,743 | Upgrade
|
| Treasury Stock | -35 | -38 | -15 | -15 | -15 | - | Upgrade
|
| Comprehensive Income & Other | 119 | 301 | 17 | 18 | -121 | -123 | Upgrade
|
| Total Common Equity | 8,831 | 9,141 | 8,493 | 6,787 | 5,889 | 5,287 | Upgrade
|
| Minority Interest | 84 | 89 | 96 | 69 | 85 | 30 | Upgrade
|
| Shareholders' Equity | 8,915 | 9,230 | 8,589 | 6,856 | 5,974 | 5,317 | Upgrade
|
| Total Liabilities & Equity | 21,749 | 21,195 | 19,310 | 17,349 | 16,370 | 15,698 | Upgrade
|
| Total Debt | 10,497 | 10,097 | 8,618 | 8,896 | 8,581 | 9,035 | Upgrade
|
| Net Cash (Debt) | -6,584 | -6,804 | -5,014 | -6,068 | -6,210 | -7,020 | Upgrade
|
| Net Cash Per Share | -813.09 | -840.11 | -628.52 | -913.63 | -934.94 | -1056.54 | Upgrade
|
| Filing Date Shares Outstanding | 8.12 | 8.1 | 8.14 | 8.14 | 6.64 | 6.59 | Upgrade
|
| Total Common Shares Outstanding | 8.12 | 8.1 | 8.14 | 6.64 | 6.64 | 6.65 | Upgrade
|
| Working Capital | 5,714 | 4,139 | 4,102 | 2,847 | 3,012 | 3,587 | Upgrade
|
| Book Value Per Share | 1087.88 | 1128.50 | 1043.71 | 1022.55 | 886.25 | 795.33 | Upgrade
|
| Tangible Book Value | 8,406 | 8,696 | 8,018 | 6,278 | 5,344 | 4,707 | Upgrade
|
| Tangible Book Value Per Share | 1035.53 | 1073.57 | 985.33 | 945.86 | 804.23 | 708.08 | Upgrade
|
| Order Backlog | - | 2,942 | 3,624 | 2,912 | 1,514 | 2,633 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.